Abstract
Of 113 methyl isocyanate (MIC)-exposed subjects studied initially at Bhopal, India, 79, 56, 68, and 87 were followed with clinical, lung function, radiographic, and immunologic tests at 3, 6, 12, 18, and 24 months. Though our cohort consisted of subjects at all ages showing a varied severity of initial illness, fewer females and young subjects were seen. Initially all had eye problems, but dominant symptoms were exertional dyspnea, cough, chest pain, sputum, and muscle weakness. A large number showed persistent depression mixed with anxiety, with disturbances of personality parameters. The early radiographic changes were lung edema, overinflation, enlarged heart, pleural scars, and consolidation. The persistent changes seen were interstitial deposits. Lung functions showed mainly restrictive changes with small airway obstruction; there was impairment of oxygen exchange. Oxygen exchange improved at 3-6 months, and spirometry improved at 12 months, only to decline later. The expiratory flow rates pertaining to large and medium airway function improved, but those for small airways remained low. There were changes of alveolitis in bronchoalveolar lavage fluid on fiber optic bronchoscopy, and in 11 cases positive MIC-specific antibodies to IgM, IgG, and IgE were demonstrated. On follow up, only 48% of the subjects were clinically stable, while 50% showed fluctuations. Thirty-two percent of the subjects had lung function fluctuations. Detailed sequential behavior over 2-4 years was predicted for dyspnea, forced vital capacity, maximum expiratory flow rate (0.25-0.75), peak expiratory flow rate, VO2, and depression score. A model for clinical behavior explained a total variance of 52.4% by using the factors of cough, PCO2 and X-ray zones in addition to above five parameters. The behavior of the railway colony group (1640 patients) revealed a similar pattern of illness. When this observed pattern of changes was transferred to the affected Bhopal city sections (with an equitable age-sex distribution), our model results were again validated. Thus the picture of MIC-induced disease seems similar despite the differences for age-sex and initial severity of illness in our cohort and in the population of Bhopal city as predicted by our model.
Full text
PDF












Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alarie Y., Ferguson J. S., Stock M. F., Weyel D. A., Schaper M. Sensory and pulmonary irritation of methyl isocyanate in mice and pulmonary irritation and possible cyanidelike effects of methyl isocyanate in guinea pigs. Environ Health Perspect. 1987 Jun;72:159–167. doi: 10.1289/ehp.8772159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Andersson N., Kerr Muir M., Mehra V., Salmon A. G. Exposure and response to methyl isocyanate: results of a community based survey in Bhopal. Br J Ind Med. 1988 Jul;45(7):469–475. doi: 10.1136/oem.45.7.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bucher J. R., Boorman G. A., Gupta B. N., Uraih L. C., Hall L. B., Stefanski S. A. Two-hour methyl isocyanate inhalation exposure and 91-day recovery: a preliminary description of pathologic changes in F344 rats. Environ Health Perspect. 1987 Jun;72:71–75. doi: 10.1289/ehp.877271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bucher J. R., Gupta B. N., Adkins B., Jr, Thompson M., Jameson C. W., Thigpen J. E., Schwetz B. A. Toxicity of inhaled methyl isocyanate in F344/N rats and B6C3F1 mice. I. Acute exposure and recovery studies. Environ Health Perspect. 1987 Jun;72:53–61. doi: 10.1289/ehp.877253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bucher J. R., Gupta B. N., Thompson M., Adkins B., Jr, Schwetz B. A. The toxicity of inhaled methyl isocyanate in F344/N rats and B6C3F1 mice. II. Repeated exposure and recovery studies. Environ Health Perspect. 1987 Jun;72:133–138. doi: 10.1289/ehp.8772133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Charles J., Bernstein A., Jones B., Jones D. J., Edwards J. H., Seal R. M., Seaton A. Hypersensitivity pneumonitis after exposure to isocyanates. Thorax. 1976 Apr;31(2):127–136. doi: 10.1136/thx.31.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Deo M. G., Gangal S., Bhisey A. N., Somasundaram R., Balsara B., Gulwani B., Darbari B. S., Bhide S., Maru G. B. Immunological, mutagenic & genotoxic investigations in gas exposed population of Bhopal. Indian J Med Res. 1987;86 (Suppl):63–76. [PubMed] [Google Scholar]
- Dutta K. K., Gupta G. S., Mishra A., Joshi A., Tandon G. S., Ray P. K. Inhalation toxicity studies of methyl isocyanate (MIC) in rats: Part I--Pulmonary pathology and genotoxicity evaluation. Indian J Exp Biol. 1988 Mar;26(3):177–182. [PubMed] [Google Scholar]
- Fedde M. R., Dodd D. E., Troup C. M., Fowler E. H. Biological effects of short-term, high-concentration exposure to methyl isocyanate. III. Influence on gas exchange in the guinea pig lung. Environ Health Perspect. 1987 Jun;72:29–33. doi: 10.1289/ehp.877229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gupta B. N., Rastogi S. K., Chandra H., Mathur A. K., Mathur N., Mahendra P. N., Pangtey B. S., Kumar S., Kumar P., Seth R. K. Effect of exposure to toxic gas on the population of Bhopal: Part I--Epidemiological, clinical, radiological & behavioral studies. Indian J Exp Biol. 1988 Mar;26(3):149–160. [PubMed] [Google Scholar]
- KIMMERLE G., EBEN A. ZUR TOXICITAET VON METHYLISOCYANAT UND DESSEN QUANTITATIVER BESTIMMUNG IN DER LUFT. Arch Toxikol. 1964 May 27;20:235–241. [PubMed] [Google Scholar]
- Kamat S. R., Kamat G. R., Salpekar V. Y., Lobo E. Distinguishing byssinosis from chronic obstructive pulmonary disease. Results of a prospective five-year study of cotton mill workers in India. Am Rev Respir Dis. 1981 Jul;124(1):31–40. doi: 10.1164/arrd.1981.124.1.31. [DOI] [PubMed] [Google Scholar]
- Kamat S. R., Mahashur A. A., Tiwari A. K., Potdar P. V., Gaur M., Kolhatkar V. P., Vaidya P., Parmar D., Rupwate R., Chatterjee T. S. Early observations on pulmonary changes and clinical morbidity due to the isocyanate gas leak at Bhopal. J Postgrad Med. 1985 Apr;31(2):63–72. [PubMed] [Google Scholar]
- Kamat S. R., Patel M. H., Kolhatkar V. P., Dave A. A., Mahashur A. A. Sequential respiratory changes in those exposed to the gas leak at Bhopal. Indian J Med Res. 1987;86 (Suppl):20–38. [PubMed] [Google Scholar]
- Karol M. H., Kamat S. R. The antibody response to methyl isocyanate: experimental and clinical findings. Bull Eur Physiopathol Respir. 1987 Nov-Dec;23(6):591–597. [PubMed] [Google Scholar]
- Karol M. H. Survey of industrial workers for antibodies to toluene diisocyanate. J Occup Med. 1981 Nov;23(11):741–747. doi: 10.1097/00043764-198111000-00007. [DOI] [PubMed] [Google Scholar]
- Misra N. P., Pathak R., Gaur K. J., Jain S. C., Yesikar S. S., Manoria P. C., Sharma K. N., Tripathi B. M., Asthana B. S., Trivedi H. H. Clinical profile of gas leak victims in acute phase after Bhopal episode. Indian J Med Res. 1987;86 (Suppl):11–19. [PubMed] [Google Scholar]
- Rastogi S. K., Gupta B. N., Husain T., Kumar A., Chandra S., Ray P. K. Effect of exposure to toxic gas on the population of Bhopal: Part II--Respiratory impairment. Indian J Exp Biol. 1988 Mar;26(3):161–164. [PubMed] [Google Scholar]
- Schwetz B. A., Adkins B., Jr, Harris M., Moorman M., Sloane R. Methyl isocyanate: reproductive and developmental toxicology studies in Swiss mice. Environ Health Perspect. 1987 Jun;72:149–152. doi: 10.1289/ehp.8772149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tice R. R., Luke C. A., Shelby M. D. Methyl isocyanate: an evaluation of in vivo cytogenetic activity. Environ Mutagen. 1987;9(1):37–58. doi: 10.1002/em.2860090106. [DOI] [PubMed] [Google Scholar]
- White W. G., Morris M. J., Sugden E., Zapata E. Isocyanate-induced asthma in a car factory. Lancet. 1980 Apr 5;1(8171):756–760. doi: 10.1016/s0140-6736(80)91247-7. [DOI] [PubMed] [Google Scholar]
- Wong K. L., Stock M. F., Alarie Y. C. Evaluation of the pulmonary toxicity of plasticized polyvinyl chloride thermal decomposition products in guinea pigs by repeated CO2 challenges. Toxicol Appl Pharmacol. 1983 Sep 15;70(2):236–248. doi: 10.1016/0041-008x(83)90099-6. [DOI] [PubMed] [Google Scholar]